Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.

Robinson-Cohen C, Bartz TM, Lai D, Ikizler TA, Peacock M, Imel EA, Michos ED, Foroud TM, Akesson K, Taylor KD, Malmgren L, Matsushita K, Nethander M, Eriksson J, Ohlsson C, Mellström D, Wolf M, Ljunggren O, McGuigan F, Rotter JI, Karlsson M, Econs MJ, Ix JH, Lutsey PL, Psaty BM, de Boer IH, Kestenbaum BR.

J Am Soc Nephrol. 2018 Oct;29(10):2583-2592. doi: 10.1681/ASN.2018020192. Epub 2018 Sep 14.

PMID:
30217807
2.

Commentary on Complications of Immunosuppressive Treatments for Glomerulonephritis.

Kestenbaum BR, Seliger SL.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1276-1277. doi: 10.2215/CJN.07610618. Epub 2018 Jul 24. No abstract available.

PMID:
30042228
3.

Serum 25-Hydroxyvitamin D Concentrations Are Associated with Computed Tomography Markers of Subclinical Interstitial Lung Disease among Community-Dwelling Adults in the Multi-Ethnic Study of Atherosclerosis (MESA).

Kim SM, Zhao D, Podolanczuk AJ, Lutsey PL, Guallar E, Kawut SM, Barr RG, de Boer IH, Kestenbaum BR, Lederer DJ, Michos ED.

J Nutr. 2018 Jul 1;148(7):1126-1134. doi: 10.1093/jn/nxy066.

PMID:
29931068
4.

Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder: A Randomized Clinical Trial.

Zelnick LR, de Boer IH, Kestenbaum BR, Chonchol M, Kendrick J.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):927-928. doi: 10.2215/CJN.00480118. Epub 2018 Mar 7. No abstract available.

PMID:
29514798
5.

Transethnic Evaluation Identifies Low-Frequency Loci Associated With 25-Hydroxyvitamin D Concentrations.

Hong J, Hatchell KE, Bradfield JP, Bjonnes A, Chesi A, Lai CQ, Langefeld CD, Lu L, Lu Y, Lutsey PL, Musani SK, Nalls MA, Robinson-Cohen C, Roizen JD, Saxena R, Tucker KL, Ziegler JT, Arking DE, Bis JC, Boerwinkle E, Bottinger EP, Bowden DW, Gilsanz V, Houston DK, Kalkwarf HJ, Kelly A, Lappe JM, Liu Y, Michos ED, Oberfield SE, Palmer ND, Rotter JI, Sapkota B, Shepherd JA, Wilson JG, Basu S, de Boer IH, Divers J, Freedman BI, Grant SFA, Hakanarson H, Harris TB, Kestenbaum BR, Kritchevsky SB, Loos RJF, Norris JM, Norwood AF, Ordovas JM, Pankow JS, Psaty BM, Sanghera DK, Wagenknecht LE, Zemel BS, Meigs J, Dupuis J, Florez JC, Wang T, Liu CT, Engelman CD, Billings LK.

J Clin Endocrinol Metab. 2018 Apr 1;103(4):1380-1392. doi: 10.1210/jc.2017-01802.

PMID:
29325163
6.

The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study.

Ginsberg C, Katz R, de Boer IH, Kestenbaum BR, Chonchol M, Shlipak MG, Sarnak MJ, Hoofnagle AN, Rifkin DE, Garimella PS, Ix JH.

Bone. 2018 Feb;107:124-130. doi: 10.1016/j.bone.2017.11.011. Epub 2017 Nov 16.

PMID:
29155243
7.

Diabetes and CKD in the United States Population, 2009-2014.

Zelnick LR, Weiss NS, Kestenbaum BR, Robinson-Cohen C, Heagerty PJ, Tuttle K, Hall YN, Hirsch IB, de Boer IH.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1984-1990. doi: 10.2215/CJN.03700417. Epub 2017 Oct 20.

8.

Commentary on "Effectiveness of Treatment Modalities on Kidney Stone Recurrence".

Seliger SL, Kestenbaum BR.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1709-1710. doi: 10.2215/CJN.07780717. Epub 2017 Aug 22. No abstract available.

9.

Association of cardiovascular disease risk factors with coronary artery calcium volume versus density.

Thomas IC, Shiau B, Denenberg JO, McClelland RL, Greenland P, de Boer IH, Kestenbaum BR, Lin GM, Daniels M, Forbang NI, Rifkin DE, Hughes-Austin J, Allison MA, Jeffrey Carr J, Ix JH, Criqui MH.

Heart. 2018 Jan;104(2):135-143. doi: 10.1136/heartjnl-2017-311536. Epub 2017 Aug 16.

PMID:
28814488
10.

Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis.

Chapron A, Shen DD, Kestenbaum BR, Robinson-Cohen C, Himmelfarb J, Yeung CK.

Clin Transl Sci. 2017 Sep;10(5):395-403. doi: 10.1111/cts.12481. Epub 2017 Jul 4.

11.

Relation of Serum Vitamin D to Risk of Mitral Annular and Aortic Valve Calcium (from the Multi-Ethnic Study of Atherosclerosis).

Tibuakuu M, Zhao D, de Boer IH, Guallar E, Bortnick AE, Lutsey PL, Budoff MJ, Kizer JR, Kestenbaum BR, Michos ED.

Am J Cardiol. 2017 Aug 1;120(3):473-478. doi: 10.1016/j.amjcard.2017.05.004. Epub 2017 May 11.

12.

Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis and the Beaver Dam Eye Study.

Mehta R, Hodakowski A, Cai X, Lee KE, Kestenbaum BR, de Boer IH, Fawzi A, Wong TY, Ix J, Klein B, Klein R, Isakova T.

Ophthalmic Epidemiol. 2017 Dec;24(6):371-380. doi: 10.1080/09286586.2017.1304562. Epub 2017 Apr 12.

13.

Bone Mineral Density and Risk of Heart Failure in Older Adults: The Cardiovascular Health Study.

Fohtung RB, Brown DL, Koh WJ, Bartz TM, Carbone LD, Civitelli R, Stein PK, Chaves PH, Kestenbaum BR, Kizer JR.

J Am Heart Assoc. 2017 Mar 13;6(3). pii: e004344. doi: 10.1161/JAHA.116.004344.

14.

Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion.

Rivara MB, Zelnick LR, Hoofnagle AN, Newitt R, Tracy RP, Kratz M, Weigle DS, Kestenbaum BR.

Clin Chem. 2017 Apr;63(4):915-923. doi: 10.1373/clinchem.2016.260117. Epub 2017 Feb 10.

15.

Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.

Zelnick LR, Katz R, Young BA, Correa A, Kestenbaum BR, de Boer IH, Bansal N.

Am J Kidney Dis. 2017 Aug;70(2):199-206. doi: 10.1053/j.ajkd.2016.11.022. Epub 2017 Jan 28.

16.

Acute kidney injury in allopurinol-induced DRESS syndrome: a case report of concurrent tubulointerstitial nephritis and kidney-limited necrotizing vasculitis
.

Esposito AJ, Murphy RC, Toukatly MN, Amro OW, Kestenbaum BR, Najafian B.

Clin Nephrol. 2017 Jun;87(6):316-319. doi: 10.5414/CN108966.

PMID:
27900940
17.

Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients.

Robinson-Cohen C, Newitt R, Shen DD, Rettie AE, Kestenbaum BR, Himmelfarb J, Yeung CK.

PLoS One. 2016 Aug 11;11(8):e0161074. doi: 10.1371/journal.pone.0161074. eCollection 2016.

18.

Potassium Measures and Their Associations with Glucose and Diabetes Risk: The Multi-Ethnic Study of Atherosclerosis (MESA).

Chatterjee R, Zelnick L, Mukamal KJ, Nettleton JA, Kestenbaum BR, Siscovick DS, Ix JH, Tracy R, Hoofnagle AN, Svetkey LP, Edelman D, de Boer IH.

PLoS One. 2016 Jun 9;11(6):e0157252. doi: 10.1371/journal.pone.0157252. eCollection 2016.

19.

Chronic Kidney Disease Alters Vitamin A Homeostasis via Effects on Hepatic RBP4 Protein Expression and Metabolic Enzymes.

Jing J, Isoherranen N, Robinson-Cohen C, Petrie I, Kestenbaum BR, Yeung CK.

Clin Transl Sci. 2016 Aug;9(4):207-15. doi: 10.1111/cts.12402. Epub 2016 Jun 9.

20.

Vitamin D and Risk of Neuroimaging Abnormalities.

Littlejohns TJ, Kos K, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Kestenbaum BR, Kuller LH, Langa KM, Lopez OL, Llewellyn DJ.

PLoS One. 2016 May 11;11(5):e0154896. doi: 10.1371/journal.pone.0154896. eCollection 2016.

21.

Fibroblast Growth Factor-23 and Frailty in Elderly Community-Dwelling Individuals: The Cardiovascular Health Study.

Beben T, Ix JH, Shlipak MG, Sarnak MJ, Fried LF, Hoofnagle AN, Chonchol M, Kestenbaum BR, de Boer IH, Rifkin DE.

J Am Geriatr Soc. 2016 Feb;64(2):270-6. doi: 10.1111/jgs.13951.

22.

Vitamin D and Memory Decline: Two Population-Based Prospective Studies.

Kuźma E, Soni M, Littlejohns TJ, Ranson JM, van Schoor NM, Deeg DJ, Comijs H, Chaves PH, Kestenbaum BR, Kuller LH, Lopez OL, Becker JT, Langa KM, Henley WE, Lang IA, Ukoumunne OC, Llewellyn DJ.

J Alzheimers Dis. 2016;50(4):1099-108. doi: 10.3233/JAD-150811. Review.

23.

Tubular Secretion in CKD.

Suchy-Dicey AM, Laha T, Hoofnagle A, Newitt R, Sirich TL, Meyer TW, Thummel KE, Yanez ND, Himmelfarb J, Weiss NS, Kestenbaum BR.

J Am Soc Nephrol. 2016 Jul;27(7):2148-55. doi: 10.1681/ASN.2014121193. Epub 2015 Nov 27.

24.

Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults.

Garimella PS, Biggs ML, Katz R, Ix JH, Bennett MR, Devarajan P, Kestenbaum BR, Siscovick DS, Jensen MK, Shlipak MG, Chaves PH, Sarnak MJ.

Kidney Int. 2015 Nov;88(5):1126-34. doi: 10.1038/ki.2015.192. Epub 2015 Jul 8.

25.

Genetic and environmental factors are associated with serum 25-hydroxyvitamin D concentrations in older African Americans.

Hansen JG, Tang W, Hootman KC, Brannon PM, Houston DK, Kritchevsky SB, Harris TB, Garcia M, Lohman K, Liu Y, de Boer IH, Kestenbaum BR, Robinson-Cohen C, Siscovick DS, Cassano PA.

J Nutr. 2015 Apr;145(4):799-805. doi: 10.3945/jn.114.202093. Epub 2015 Feb 25.

26.

Self-rated health and adverse events in CKD.

Robinson-Cohen C, Hall YN, Katz R, Rivara MB, de Boer IH, Kestenbaum BR, Himmelfarb J.

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2044-51. doi: 10.2215/CJN.03140314. Epub 2014 Oct 9.

27.

Vitamin D and the risk of dementia and Alzheimer disease.

Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller LH, Langa KM, Lopez OL, Kos K, Soni M, Llewellyn DJ.

Neurology. 2014 Sep 2;83(10):920-8. doi: 10.1212/WNL.0000000000000755. Epub 2014 Aug 6.

28.

Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equation.

Robinson-Cohen C, Ix JH, Smits G, Persky M, Chertow GM, Block GA, Kestenbaum BR.

J Ren Nutr. 2014 May;24(3):194-9. doi: 10.1053/j.jrn.2014.02.001.

PMID:
24759300
29.

Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.

Garimella PS, Ix JH, Katz R, Chonchol MB, Kestenbaum BR, de Boer IH, Siscovick DS, Shastri S, Hiramoto JS, Shlipak MG, Sarnak MJ.

Atherosclerosis. 2014 Mar;233(1):91-6. doi: 10.1016/j.atherosclerosis.2013.12.015. Epub 2014 Jan 4.

30.

Physical activity and change in estimated GFR among persons with CKD.

Robinson-Cohen C, Littman AJ, Duncan GE, Weiss NS, Sachs MC, Ruzinski J, Kundzins J, Rock D, de Boer IH, Ikizler TA, Himmelfarb J, Kestenbaum BR.

J Am Soc Nephrol. 2014 Feb;25(2):399-406. doi: 10.1681/ASN.2013040392. Epub 2013 Dec 12.

31.

The authors reply:.

Yamamoto KT, Kestenbaum BR.

Kidney Int. 2013 Oct;84(4):850. doi: 10.1038/ki.2013.262. No abstract available.

32.

Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events.

Robinson-Cohen C, Hoofnagle AN, Ix JH, Sachs MC, Tracy RP, Siscovick DS, Kestenbaum BR, de Boer IH.

JAMA. 2013 Jul 10;310(2):179-88. doi: 10.1001/jama.2013.7228.

33.

Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA).

Carter CE, Katz R, Kramer H, de Boer IH, Kestenbaum BR, Peralta CA, Siscovick D, Sarnak MJ, Levey AS, Inker LA, Allison MA, Criqui MH, Shlipak MG, Ix JH.

Am J Kidney Dis. 2013 Oct;62(4):722-9. doi: 10.1053/j.ajkd.2013.05.010. Epub 2013 Jul 2.

34.

Effects of a high-protein diet on regulation of phosphorus homeostasis.

Kremsdorf RA, Hoofnagle AN, Kratz M, Weigle DS, Callahan HS, Purnell JQ, Horgan AM, de Boer IH, Kestenbaum BR.

J Clin Endocrinol Metab. 2013 Mar;98(3):1207-13. doi: 10.1210/jc.2012-2910. Epub 2013 Feb 7.

35.

Assessment of physical activity in chronic kidney disease.

Robinson-Cohen C, Littman AJ, Duncan GE, Roshanravan B, Ikizler TA, Himmelfarb J, Kestenbaum BR.

J Ren Nutr. 2013 Mar;23(2):123-31. doi: 10.1053/j.jrn.2012.04.008. Epub 2012 Jun 26.

36.

Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).

Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Rifkin D, Siscovick DS, Sarnak MJ, Shlipak MG.

J Am Coll Cardiol. 2012 Jul 17;60(3):200-7. doi: 10.1016/j.jacc.2012.03.040. Epub 2012 Jun 13.

37.

Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the Multi-Ethnic Study of Atherosclerosis.

Ix JH, Katz R, de Boer IH, Kestenbaum BR, Peralta CA, Jenny NS, Budoff M, Allison MA, Criqui MH, Siscovick D, Shlipak MG.

Clin Chem. 2012 May;58(5):887-95. doi: 10.1373/clinchem.2011.177725. Epub 2012 Feb 29.

38.

Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels.

O'Seaghdha CM, Yang Q, Glazer NL, Leak TS, Dehghan A, Smith AV, Kao WH, Lohman K, Hwang SJ, Johnson AD, Hofman A, Uitterlinden AG, Chen YD; GEFOS Consortium, Brown EM, Siscovick DS, Harris TB, Psaty BM, Coresh J, Gudnason V, Witteman JC, Liu YM, Kestenbaum BR, Fox CS, Köttgen A.

Hum Mol Genet. 2010 Nov 1;19(21):4296-303. doi: 10.1093/hmg/ddq342. Epub 2010 Aug 12.

39.

Serum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) study.

Meng J, Wassel CL, Kestenbaum BR, Collins TC, Criqui MH, Lewis CE, Cummings SR, Ix JH; Osteoporotic Fractures in Men (MrOS) Study Group.

Am J Epidemiol. 2010 Apr 15;171(8):909-16. doi: 10.1093/aje/kwq020. Epub 2010 Mar 17.

40.

Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis.

Alonso A, Nettleton JA, Ix JH, de Boer IH, Folsom AR, Bidulescu A, Kestenbaum BR, Chambless LE, Jacobs DR Jr.

Hypertension. 2010 Mar;55(3):776-84. doi: 10.1161/HYPERTENSIONAHA.109.143461. Epub 2010 Jan 18.

41.

Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis.

Peralta CA, Adeney KL, Shlipak MG, Jacobs D Jr, Duprez D, Bluemke D, Polak J, Psaty B, Kestenbaum BR.

Am J Epidemiol. 2010 Jan 1;171(1):63-71. doi: 10.1093/aje/kwp319. Epub 2009 Nov 30.

42.

Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).

Ix JH, Katz R, De Boer IH, Kestenbaum BR, Allison MA, Siscovick DS, Newman AB, Sarnak MJ, Shlipak MG, Criqui MH.

J Am Coll Cardiol. 2009 Sep 22;54(13):1176-84. doi: 10.1016/j.jacc.2009.06.017.

43.

Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis.

Kestenbaum BR, Adeney KL, de Boer IH, Ix JH, Shlipak MG, Siscovick DS.

Kidney Int. 2009 Nov;76(9):991-8. doi: 10.1038/ki.2009.298. Epub 2009 Aug 19.

44.

Allopurinol and mortality in hyperuricaemic patients.

Luk AJ, Levin GP, Moore EE, Zhou XH, Kestenbaum BR, Choi HK.

Rheumatology (Oxford). 2009 Jul;48(7):804-6. doi: 10.1093/rheumatology/kep069. Epub 2009 May 15.

45.

Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA.

Ix JH, De Boer IH, Peralta CA, Adeney KL, Duprez DA, Jenny NS, Siscovick DS, Kestenbaum BR.

Clin J Am Soc Nephrol. 2009 Mar;4(3):609-15. doi: 10.2215/CJN.04100808. Epub 2009 Feb 11.

46.

Association of serum phosphate with vascular and valvular calcification in moderate CKD.

Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR.

J Am Soc Nephrol. 2009 Feb;20(2):381-7. doi: 10.1681/ASN.2008040349. Epub 2008 Dec 10.

47.

Risk factors for incident stroke among patients with end-stage renal disease.

Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO.

J Am Soc Nephrol. 2003 Oct;14(10):2623-31.

48.

Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients.

Wasse H, Gillen DL, Ball AM, Kestenbaum BR, Seliger SL, Sherrard D, Stehman-Breen CO.

Kidney Int. 2003 Oct;64(4):1455-61.

49.

Risk of hip fracture among dialysis and renal transplant recipients.

Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL, Kestenbaum BR, Stehman-Breen C.

JAMA. 2002 Dec 18;288(23):3014-8.

PMID:
12479766

Supplemental Content

Loading ...
Support Center